Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > New Press Release - Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Feb 29, 2024 4:57pm

89 Views

Post# 35907667

RE:RE:RE:New Press Release - Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau

Imeant to write
I Fear there is another shoe to drop
He was the Chair of the Audit Commitee

No reasons given in the PR
Health reasons...nope they would have said personnal reasons
Disagreement with management ....????? This is what I suspect but the PR is numb on that
I think we deserve to know ,,,,,,If it is simply because he wants to spend more time with family thats fine ....Just tell us ....